In support of a tumour-suppressive role for FOXO acetylation, a report shows that the acetylation recruits FOXO1 to promyelocytic leukaemia (PML) protein in the nucleus to protect FOXO1 against ubiquitination and to promote its activity in pancreatic beta cells [198]. This evidence concerns the gene FOXO1 and neoplasm.